Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1982
125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14R I Misbin, S J Buynitzky, E C Almira
Regulatory Peptides|January 1, 1983
Enteric release of vasoactive intestinal peptide after a peptone meal in the dogM M Wolfe, R I Misbin, D F Gardner, et al.
New York State Journal of Medicine|March 1, 1993
Compliance with New York State's do-not-resuscitate law at Memorial Sloan-Kettering Cancer Center. A review of patient deathsR I Misbin, D O'Hare, M S Lederberg, et al.
Diabetes|May 1, 1978
Ketoacids and the insulin receptorR I Misbin, A J Pulkkinen, S A Lofton, et al.
Endocrinology|October 1, 1983
Inhibition of insulin degradation by insulin-like growth factorsR I Misbin, E C Almira, W C Duckworth, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1987
Elevated levels of plasma prorenin (inactive renin) in diabetic and nondiabetic patients with autonomic dysfunctionR I Misbin, M B Grant, M S Pecker, et al.
The American Journal of Physiology|June 1, 1985
Preferential binding of vasoactive intestinal peptide to hepatic nonparenchymal cellsD F Gardner, M S Kilberg, M M Wolfe, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1986
Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysisD F Gardner, D R Mars, R G Thomas, et al.
The American Journal of Physiology|August 1, 1982
Uptake of vasoactive intestinal peptide by rat liverR I Misbin, M M Wolfe, P Morris, et al.
Metabolism: Clinical and Experimental|June 1, 1983
Resistance to subcutaneous and intramuscular insulin associated with deficiency of insulin-like growth factor (IGF) 2R I Misbin, E C Almira, E R Froesch, et al.
Pageof 4